Last month the National Institute for Health and Care Excellence (NICE) released a statement on the management of stress urinary incontinence (SUI) and pelvic prolapse in women.
In the report, NICE suggested that non-surgical treatments should be offered as a first-line option to patients suffering from these conditions.
It was stated that if a woman’s chosen intervention is not available from a consulting surgeon, she should be referred to an alternative surgeon but surgical interventions using surgical mesh/tape should only be considered when non-surgical options have failed or are not possible.
Sir Andrew Dillon, chief executive of NICE said, “It is important that every woman is supported to make decisions that are right for her, consents to a procedure, and fully understands the benefits and risks of the procedure being offered before consenting to it. Where surgical mesh/tape could be an option, there is almost always another intervention recommended in our guideline, which does not involve surgical mesh/tape. If a surgeon cannot provide a full range of choices to the patient, then she should be referred to one who can.”
Surgeon Miss Mayoni Gooneratne, who has previously expressed her concerns regarding the safety of certain vaginal rejuvenation treatments added, “This statement from NICE is a welcome breakthrough for women who suffer daily from debilitating conditions such as SUI or prolapse. This means they will be offered the treatment of their choice in discussion with their clinician, giving them the opportunity to access non-surgical options such as physical therapy, medicines and lifestyle interventions.”